Back to Trades
Other4
Bausch Health Companies Inc.
BHC
Total Value
$7.8M
Company Information
- Company Name
- Bausch Health Companies Inc.
- Ticker Symbol
- BHC
- CIK
- 0000885590
Insider Information
- Name
- APPIO THOMAS
- Role
- Chief Executive Officer, Director
- Location
- BRIDGEWATER, NJ
DirectorOfficer
Filing Details
- Filing Date
- Mar 3, 2026
- Transaction Date
- Feb 27, 2026
- Accession Number
- 0000885590-26-000037
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 27, 2026 | Common Shares, No Par Value | 83,093 | $5.93 | Tax Withholding | $492.7K |
| Mar 2, 2026 | Common Shares, No Par Value | 83,705 | $5.95 | Tax Withholding | $498.0K |
| Mar 2, 2026 | Common Shares, No Par Value | 1,137,862 | $5.95 | Other | $6.8M |
Footnotes
- (F1)This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.
- (F2)This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.
- (F3)Reflects the settlement in cash of 1,137,862 performance share unit awards originally granted to the Reporting Person under the Bausch Health Companies, Inc. 2014 Omnibus Incentive Plan on March 2, 2023, which, as previously reported on February 11, 2026, were earned, on February 9, 2026, upon certification by the Talent and Compensation Committee (the "Committee") of the Board of Directors of the Issuer of the level of achievement of the applicable performance metrics, but remained subject to service-based vesting. As disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on March 2, 2026, the Committee subsequently took action to provide for the payment of such earned performance share unit awards in cash rather than Issuer common stock upon vesting. The settlement in cash is exempt under Rule 16b-3(e).